FDA
-
-
-
-
-
-
-
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer
-
322,091 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

